Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- 1 October 2011
- journal article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 91 (2), 596-602
- https://doi.org/10.1016/j.yexmp.2011.06.005
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Molecular portraits of intratumoral heterogeneity in human ovarian cancerCancer Letters, 2011
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsOncogene, 2008
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- Somatic Activation of KIT in Distinct Subtypes of MelanomaJournal of Clinical Oncology, 2006
- Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian CancerCancer Research, 2005
- Induction of Stem Cell Factor/c-Kit/Slug Signal Transduction in Multidrug-resistant Malignant Mesothelioma CellsJournal of Biological Chemistry, 2004
- Therapeutic implications of cancer stem cellsCurrent Opinion in Genetics & Development, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer GroupBlood, 1994